- Home
- SNOA vs SHPH Comparison
SNOA vs SHPH Comparison
Compare SNOA & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOA
- SHPH
- Stock Information
- Founded
- SNOA 1999
- SHPH 2012
- Country
- SNOA United States
- SHPH United States
- Employees
- SNOA N/A
- SHPH N/A
- Industry
- SNOA Biotechnology: Pharmaceutical Preparations
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- SNOA Health Care
- SHPH Health Care
- Exchange
- SNOA Nasdaq
- SHPH Nasdaq
- Market Cap
- SNOA 4.6M
- SHPH 3.9M
- IPO Year
- SNOA 2007
- SHPH 2022
- Fundamental
- Price
- SNOA $2.56
- SHPH $1.00
- Analyst Decision
- SNOA
- SHPH
- Analyst Count
- SNOA 0
- SHPH 0
- Target Price
- SNOA N/A
- SHPH N/A
- AVG Volume (30 Days)
- SNOA 97.7K
- SHPH 3.4M
- Earning Date
- SNOA 11-07-2024
- SHPH 11-13-2024
- Dividend Yield
- SNOA N/A
- SHPH N/A
- EPS Growth
- SNOA N/A
- SHPH N/A
- EPS
- SNOA N/A
- SHPH N/A
- Revenue
- SNOA $13,547,000.00
- SHPH N/A
- Revenue This Year
- SNOA $36.00
- SHPH N/A
- Revenue Next Year
- SNOA $25.26
- SHPH N/A
- P/E Ratio
- SNOA N/A
- SHPH N/A
- Revenue Growth
- SNOA 11.81
- SHPH N/A
- 52 Week Low
- SNOA $2.52
- SHPH $0.98
- 52 Week High
- SNOA $9.40
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- SNOA 39.95
- SHPH 35.05
- Support Level
- SNOA $2.76
- SHPH $1.22
- Resistance Level
- SNOA $2.84
- SHPH $1.23
- Average True Range (ATR)
- SNOA 0.21
- SHPH 0.20
- MACD
- SNOA -0.01
- SHPH -0.04
- Stochastic Oscillator
- SNOA 0.01
- SHPH 1.73
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.